Related Experiment Video
Updated: Aug 21, 2026

Measurements of Physiological Stress Responses in C. Elegans
Published on: May 21, 2020
Clostridium difficile toxin A induces expression of the stress-induced early gene product RhoB
Ralf Gerhard1, Helma Tatge, Harald Genth
1Institute of Toxicology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. gerhard.ralf@mh-hannover.de
Abstract:
Clostridium difficile toxin A monoglucosylates the Rho family GTPases Rho, Rac, and Cdc42. Glucosylation leads to the functional inactivation of Rho GTPases and causes disruption of the actin cytoskeleton. A cDNA microarray revealed the immediate early gene rhoB as the gene that was predominantly up-regulated in colonic CaCo-2 cells after treatment with toxin A. This toxin A effect was also detectable in epithelial cells such as HT29 and Madin-Darby canine kidney cells, as well as NIH 3T3 fibroblasts. The expression of RhoB was time-dependent and correlated with the morphological changes of cells. The up-regulation of RhoB was approximately 15-fold and was based on the de novo synthesis of the GTPase because cycloheximide completely inhibited the toxin A effect. After 8 h, a steady state was reached, with no further increase in RhoB. The p38 MAPK inhibitor SB202190 reduced the expression of RhoB, indicating a participation of the p38 MAPK in this stress response. Surprisingly, newly formed RhoB protein was only partially glucosylated by toxin A, sparing a pool of potentially active RhoB, as checked by sequential C3bot-catalyzed ADP-ribosylation. A pull-down assay in fact revealed a significant amount of active RhoB in toxin A-treated cells that was not present in control cells. We demonstrate for the first time that toxin A has not only the property to inactivate the GTPases RhoA, Rac1, and Cdc42 by glucosylation, but it also has the property to generate active RhoB that likely contributes to the overall picture of toxin treatment.
Insights
Clostridium difficile toxin A inactivates Rho GTPases but surprisingly also generates active RhoB. This active RhoB likely contributes to cellular changes observed during toxin A treatment.
Area of Science:
- Cell Biology
- Microbiology
- Molecular Biology
Background:
- Clostridium difficile toxin A (TcdA) is a potent virulence factor.
- TcdA monoglucosylates Rho GTPases, leading to actin cytoskeleton disruption.
- The cellular response to TcdA, particularly regarding Rho GTPase expression, requires further elucidation.
Purpose of the Study:
- To investigate the effect of TcdA on Rho GTPase expression, specifically RhoB.
- To identify the signaling pathways involved in TcdA-induced RhoB up-regulation.
- To determine the functional state of RhoB following TcdA treatment.
Main Methods:
- cDNA microarray analysis to identify differentially expressed genes.
- Cell culture (CaCo-2, HT29, MDCK, NIH 3T3) and treatment with TcdA.
- Inhibition studies using cycloheximide and p38 MAPK inhibitor (SB202190).
- Assessment of RhoB activity using C3bot-catalyzed ADP-ribosylation and pull-down assays.
Main Results:
- TcdA treatment significantly up-regulated the immediate early gene rhoB in various cell types.
- RhoB up-regulation was dependent on de novo protein synthesis and involved the p38 MAPK pathway.
- A significant pool of active RhoB was detected in TcdA-treated cells, indicating partial glucosylation.
- Active RhoB levels were higher in TcdA-treated cells compared to controls.
Conclusions:
- TcdA not only inactivates RhoA, Rac1, and Cdc42 but also induces the generation of active RhoB.
- The p38 MAPK pathway mediates the stress response leading to RhoB expression.
- The newly generated active RhoB likely plays a role in the cellular pathology induced by TcdA.
Related Concept Videos
Other Stress Responses in Bacteria
Stringent Response in E. coli
Regulation of the Unfolded Protein Response
Bacterial Toxins
Diphtheria
Gene Regulation During Sporulation
